Combination of deferasirox and deferoxamine in management of iron overload in myelodysplastic syndromes (MDS): An update in a hepatopatic patient

被引：0
|
作者：
Cerchione, C. [1 ]
Cerciello, G. [1 ]
Della Pepa, R. [1 ]
Pugliese, N. [1 ]
Marano, L. [1 ]
Vitagliano, O. [1 ]
Matarazzo, M. [2 ]
Pane, F. [1 ]
Alfinito, F. [1 ]
机构：
[1] Univ Naples Federico II, Hematol, Naples, Italy
[2] Univ Naples Federico II, Clincal Med, Naples, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70235-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-187
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [41] Iron overload and myelodysplastic syndromes.
    Rose, C
    Cambier, N
    Mahieu, M
    Ernst, O
    Fenaux, P
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2001, 8 (05) : 422 - 432
  • [42] Delineating parameters of iron overload in MDS patients treated with deferasirox
    Leitch, Heather A.
    LEUKEMIA RESEARCH, 2010, 34 (12) : 1556 - 1557
  • [43] Management of Transfusion-Related Iron Overload in Patients With Myelodysplastic Syndromes
    Shah, Jayshree
    Kurtin, Sandra E.
    Arnold, Louise
    Lindroos-Kolqvist, Petra
    Tinsley, Sara
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2012, 16 (03) : 37 - 46
  • [44] Real-World Experience with Anemia and Iron Overload Therapies in Myelodysplastic Syndromes (MDS): Treatment Sequence, Duration, and Patient Compliance
    Huey, Krystal
    Zhao, Ruizhi
    Gu, Tao
    Le, Trong Kim
    Jones, Shalon
    Bueno, Luciana
    Tang, Derek
    BLOOD, 2020, 136
  • [45] Update of the GIMEMA MDS0306 study: Deferasirox for lower risk transfusion-dependent patients with myelodysplastic syndromes
    Piciocchi, Alfonso
    Sargentini, Valeria
    Cotugno, Francesca
    Bontempi, Katia
    Beltrami, Germana
    Di Tucci, Anna Angela
    Riva, Marta
    Quaresmini, Giulia
    Vallisa, Daniele
    Finelli, Carlo
    Borin, Lorenza
    Fazi, Paola
    Vignetti, Marco
    Angelucci, Emanuele
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (05) : 442 - 443
  • [46] Iron overload and chelation therapy in myelodysplastic syndromes
    Temraz, Sally
    Santini, Valeria
    Musallam, Khaled
    Taher, Ali
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 91 (01) : 64 - 73
  • [47] Consensus statement on iron overload in myelodysplastic syndromes
    Bennett, John M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (11) : 858 - 861
  • [48] Therapy of Myelodysplastic Syndromes (MDS) in elderly patient
    Stauder, R.
    Deschler, B.
    ONKOLOGIE, 2008, 31 : 21 - 22
  • [49] Is Deferasirox Safe and Effective in Very Elderly Patients (> 75 Years) with Myelodysplastic Syndromes and Transfusional Iron Overload?
    Latagliata, Roberto
    Niscola, Pasquale
    Volpe, Antonio
    Barate, Claudia
    Campagna, Alessia
    Poloni, Antonella
    Sarlo, Chiara
    Faglioni, Laura
    De Benedictis, Daniela
    Carmosino, Ida
    Fenu, Susanna
    Spiriti, Maria Antonietta Aloe
    Galimberti, Sara
    Breccia, Massimo
    Foa, Robin
    Finelli, Carlo
    BLOOD, 2017, 130
  • [50] Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia
    Cappellini, Maria Domenica
    Bejaoui, Mohamed
    Agaoglu, Leyla
    Porter, John
    Coates, Thomas
    Jeng, Michael
    Lai, Maria Eliana
    Mangiagli, Antonio
    Strauss, Gabriele
    Girot, Robert
    Watman, Nora
    Ferster, Alina
    Loggetto, Sandra
    Abish, Sharon
    Cario, Holger
    Zoumbos, Nicolaos
    Vichinsky, Elliott
    Opitz, Herbert
    Ressayre-Djaffer, Catherine
    Abetz, Linda
    Rofail, Diana
    Baladi, Jean-Francois
    CLINICAL THERAPEUTICS, 2007, 29 (05) : 909 - 917
12345